Edition:
United States

Adamis Pharmaceuticals Corp (ADMP.PH)

ADMP.PH on Philadelphia Stock Exchange

4.25USD
24 Mar 2017
Change (% chg)

$0.08 (+1.80%)
Prev Close
$4.18
Open
$4.25
Day's High
$4.25
Day's Low
$4.25
Volume
398
Avg. Vol
1,409
52-wk High
$10.60
52-wk Low
$2.47

ADMP.PH

Chart for ADMP.PH

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: -0.58
Market Cap(Mil.): $92.81
Shares Outstanding(Mil.): 21.58
Dividend: --
Yield (%): --

Financials

  ADMP.PH Industry Sector
P/E (TTM): -- 29.17 29.94
EPS (TTM): -1.53 -- --
ROI: -111.20 13.48 13.01
ROE: -128.15 14.39 14.16

BRIEF-Adamis Pharmaceuticals announces FDA acceptance of its Epinephrine Pre-filled Syringe

* Adamis Pharmaceuticals announces FDA acceptance of resubmission of its Epinephrine pre-filled syringe NDA Source text for Eikon: Further company coverage:

Jan 19 2017

More From Around the Web

Competitors

  Price Chg
GlaxoSmithKline plc (GSK.L) 1,670.50 -4.50

Earnings vs. Estimates